Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
34
# OF OVERLAPPING
HOLDINGS
FHLC
334
HOLDINGS
12%
ALSO IN CANC
CANC
56
HOLDINGS
61%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.0% | 4.2% | 4.2% |
|
MERCK & CO. INC. | 4.0% | 3.8% | 3.8% |
|
AMGEN INC | 2.7% | 2.5% | 2.5% |
|
ABBVIE INC | 6.1% | 2.3% | 2.3% |
|
JOHNSON & JOHNSON | 7.5% | 2.0% | 2.0% |
FHLC Overweight Relative to CANC
|
ELI LILLY & CO | 8.8% |
|
JOHNSON & JOHNSON | 5.5% |
|
UNITEDHEALTH GROUP INC | 4.5% |
|
ABBVIE INC | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
ABBOTT LABORATORIES | 3.3% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
DANAHER CORP | 2.2% |
|
BOSTON SCIENTIFIC CORP | 2.1% |
|
PFIZER INC | 2.1% |
FHLC Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.9% |
 |
NOVARTIS AG | -4.4% |
|
BRIDGEBIO PHARMA, INC. | -4.4% |
 |
ASTRAZENECA PLC | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
NUVALENT, INC. CLASS A | -3.3% |
|
COGENT BIOSCIENCES INC | -3.1% |
|
IMMUNOME, INC. | -3.0% |
|
CELCUITY INC. | -2.5% |